After treatment with BN for 3 months, BMI, fasting blood glucose, glycosylated hemoglobin, visceral and subcutaneous fat, silk protein E1, leptin, C-reactive protein (CRP), and tumor necrosis factor decreased significantly
Strategies for maintaining weight loss after stopping peptides improve long-term success
Questions you want answered write them down so you dont forget
These are usually tolerable and improve as the body adapts
Tirzepatide, a dual GLP-1/GIP agonist, is already approved as Mounjaro (for type 2 diabetes) and Zepbound (for obesity)
There are also state lawsuits against the manufacturers of Ozempic and other similar drugs